Clinical

Articles

Researchers from the Mount Sinai COVID Informatics Center report improved survival rates in COVID patients treated with anticoagulants. 

Anticoagulants Improve Survival Rates in Patients With COVID-19

Administration time for warfarin did not affect the stability of the drug’s anticoagulation effect, a new study showed. 

Time of Day for Taking Warfarin Does Not Affect Anticoagulation Stability

First and currently only biological targeting P-selectin.

Crizanlizumab for Sickle Cell Pain Reduction Approved by FDA

Also indciated to control bleeding and perioperative management.

Wilate Approved for Hemophilia A Treatment 

Black box warns of increased risk of blood clots and death.

New Warnings for Tofacitinib Issued by FDA

Christine Blank is a contributing editor. 

Study finds higher Ischemic events and mortality in transcatheter valve replacement patients taking non-vitamin K antagonist oral anticoagulants versus vitamin K antagonists.

Study: VKAs Better Protect Aortic Valve Replacement Patients

Low-risk atrial fibrillation patients who take oral anticoagulants have a lower risk of dementia than those who do not, a study says.

AF Patients Taking OACs Have Lower Dementia Risk

The use of direct‐acting oral anticoagulants has increased among nursing home residents with atrial fibrillation.

DOAC Use Increasing in Nursing Homes

Overestimating the bleeding risk of anticoagulants may lead to poor compliance.

Atrial Fibrillation Patients Often Overestimate Stroke and Bleeding Risks

Fragmin, a low-molecular-weight heparin dalteparin sodium injection, was approved for symptomatic venous thromboembolism.